Ming Tan
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 20
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 13
-
- RNA modifications and cancer 10
- Metabolism, Diabetes, and Cancer 9
- Co-authors
- Dihua Yu (17 shared papers)Jianrong Lu (12 shared papers)Ethan B. Butler (3 shared papers)Yinglan Zhao (1 shared paper)Mien‐Chie Hung (5 shared papers)Qingsong Cai (3 shared papers)Øystein Fodstad (13 shared papers)Xiaoyan Zhou (4 shared papers)
- Journals
- PLoS ONE (9 papers)Cell Death and Disease (8 papers)Cancer Research (8 papers)Oncotarget (7 papers)Journal of Ethnopharmacology (6 papers)
- Partner nations
- United StatesChinaMalaysia
In The Last Decade
Ming Tan
216 papers receiving 14.1k citations
Ming Tan's Hit Papers
Peers
Comparison fields: 5 of 184
- Cancer Research 4.0k
- Oncology 4.0k
- Health Informatics 155
- Molecular Biology 7.0k
- Immunology 1.3k
Countries citing papers authored by Ming Tan
This map shows the geographic impact of Ming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Tan more than expected).
Fields of papers citing papers by Ming Tan
This network shows the impact of papers produced by Ming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Tan. The network helps show where Ming Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Hit paper breakdown → | 2004 | 1522 |
| 2 | Targeting cellular metabolism to improve cancer therapeutics Hit paper breakdown → | 2013 | 853 |
| 3 | The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism Hit paper breakdown → | 2014 | 641 |
| 4 | 2004 | 465 | |
| 5 | 1996 | 419 | |
| 6 | 2010 | 367 | |
| 7 | 2018 | 364 | |
| 8 | 2010 | 342 | |
| 9 | 1998 | 319 | |
| 10 | 2004 | 265 | |
| 11 | 2011 | 250 | |
| 12 | 2011 | 236 | |
| 13 | The role of ChatGPT in scientific communication: writing better scientific review articles. | 2023 | 228 |
| 14 | 2009 | 224 | |
| 15 | 2017 | 215 | |
| 16 | 2011 | 213 | |
| 17 | Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. | 1997 | 192 |
| 18 | 2012 | 191 | |
| 19 | Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. | 1996 | 189 |
| 20 | 2017 | 173 |
About Ming Tan
Ming Tan is a scholar working on Cancer Research, Molecular Biology, Oncology, Pharmacology and Complementary and alternative medicine, having authored 225 papers that have together received 14.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (20 papers), MicroRNA in disease regulation (15 papers), HER2/EGFR in Cancer Research (14 papers), Cancer-related molecular mechanisms research (13 papers), Cancer-related Molecular Pathways (12 papers), Autophagy in Disease and Therapy (11 papers), RNA modifications and cancer (10 papers) and Metabolism, Diabetes, and Cancer (9 papers). The work is most often cited by research in Cancer Research (4.0k citations), Oncology (4.0k citations), Health Informatics (155 citations), Molecular Biology (7.0k citations) and Immunology (1.3k citations). Ming Tan has collaborated with scholars based in United States, China and Malaysia. Frequent co-authors include Dihua Yu, Jianrong Lu, Ethan B. Butler, Yinglan Zhao, Mien‐Chie Hung, Qingsong Cai, Øystein Fodstad, Xiaoyan Zhou, Keng‐Hsueh Lan and Kristine S. Klos. Their work appears in journals such as PLoS ONE, Cell Death and Disease, Cancer Research, Oncotarget and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.